Your search returned 5 results.

Results
	1.	The Effects of Lansoprazole on the Disposition of Antipyrine and Indocyanine Green in Normal Human Subjects. [electronic resource] by St Peter, John V Awni, Walid M Granneman, G. Richard Karol, Michael D Publication details: American journal of therapeutics Aug 1995 In: American journal of therapeutics vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules. [electronic resource] by Amer, Fouad Karol, Michael D Pan, Wei-Jian Griffin, Janice S Lukasik, Nancy L Locke, Charles S Chiu, Yi-Lin Producer: 20050428 In: Clinical therapeutics vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma. [electronic resource] by Goyal, Lipika Wadlow, Raymond C Blaszkowsky, Lawrence S Wolpin, Brian M Abrams, Thomas A McCleary, Nadine Jackson Sheehan, Susan Sundaram, Eamala Karol, Michael D Chen, John Zhu, Andrew X Producer: 20150918 In: Investigational new drugs vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies. [electronic resource] by Goldman, Jonathan W Raju, Robert N Gordon, Gregory A El-Hariry, Iman Teofilivici, Florentina Vukovic, Vojo M Bradley, Robert Karol, Michael D Chen, Yu Guo, Wei Inoue, Takayo Rosen, Lee S Producer: 20130916 In: BMC cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. [electronic resource] by DeAngelo, Daniel J Stone, Richard M Heaney, Mark L Nimer, Stephen D Paquette, Ronald L Klisovic, Rebecca B Caligiuri, Michael A Cooper, Michael R Lecerf, Jean-Michel Karol, Michael D Sheng, Shihong Holford, Nick Curtin, Peter T Druker, Brian J Heinrich, Michael C Producer: 20070104 In: Blood vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)